These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 8926925)

  • 1. [The characteristics of the clinical course of malaria in Ethiopia].
    Loban KM; Popova SP
    Med Parazitol (Mosk); 1996; (2):10-3. PubMed ID: 8926925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Concurrent dengue and malaria due to Plasmodium falciparum and P. vivax.
    Kaushik RM; Varma A; Kaushik R; Gaur KJ
    Trans R Soc Trop Med Hyg; 2007 Oct; 101(10):1048-50. PubMed ID: 17568646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The course of malignant forms of tropical malaria in the native population of endemic foci in Ethiopia].
    Popova SP; Loban KM
    Med Parazitol (Mosk); 1996; (2):13-5. PubMed ID: 8926926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid immunochromatography-based detection of mixed-species malaria infection in Pakistan.
    Beg MA; Ali SS; Haqqee R; Khan MA; Qasim Z; Hussain R; Smego RA
    Southeast Asian J Trop Med Public Health; 2005 May; 36(3):562-4. PubMed ID: 16124417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Persistent ICT malaria P.f/P.v panmalarial and HRP2 antigen reactivity after treatment of Plasmodium falciparum malaria is associated with gametocytemia and results in false-positive diagnoses of Plasmodium vivax in convalescence.
    Tjitra E; Suprianto S; McBroom J; Currie BJ; Anstey NM
    J Clin Microbiol; 2001 Mar; 39(3):1025-31. PubMed ID: 11230422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sulfadoxine-pyrimethamine plus artesunate compared with chloroquine for the treatment of vivax malaria in areas co-endemic for Plasmodium falciparum and P. vivax: a randomised non-inferiority trial in eastern Afghanistan.
    Kolaczinski K; Durrani N; Rahim S; Rowland M
    Trans R Soc Trop Med Hyg; 2007 Nov; 101(11):1081-7. PubMed ID: 17707447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative features and outcomes of malaria at a tertiary care hospital in Karachi, Pakistan.
    Beg MA; Sani N; Mehraj V; Jafri W; Khan MA; Malik A; Menezes E; Hussain R; Smego R
    Int J Infect Dis; 2008 Jan; 12(1):37-42. PubMed ID: 17576086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low efficacy of amodiaquine or chloroquine plus sulfadoxine-pyrimethamine against Plasmodium falciparum and P. vivax malaria in Papua New Guinea.
    Marfurt J; Müeller I; Sie A; Maku P; Goroti M; Reeder JC; Beck HP; Genton B
    Am J Trop Med Hyg; 2007 Nov; 77(5):947-54. PubMed ID: 17984359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A mixed malaria infection: is Plasmodium vivax good for you?
    Whitehorn J; Coltart C; Manser D; Doherty T
    Trans R Soc Trop Med Hyg; 2010 Mar; 104(3):240-1. PubMed ID: 19740502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mefloquine is highly efficacious against chloroquine-resistant Plasmodium vivax malaria and Plasmodium falciparum malaria in Papua, Indonesia.
    Maguire JD; Krisin ; Marwoto H; Richie TL; Fryauff DJ; Baird JK
    Clin Infect Dis; 2006 Apr; 42(8):1067-72. PubMed ID: 16575721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Self-treatment of malaria in rural communities, Butajira, southern Ethiopia.
    Deressa W; Ali A; Enqusellassie F
    Bull World Health Organ; 2003; 81(4):261-8. PubMed ID: 12764492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal failure in malaria.
    Das BS
    J Vector Borne Dis; 2008 Jun; 45(2):83-97. PubMed ID: 18592837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Epidemiological and therapeutic aspects of plasmodial infection from Plasmodium vivax].
    Nicolas X; Granier H; Martin J; Klotz F
    Med Trop (Mars); 2000; 60(4):402-8. PubMed ID: 11436600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deployment of early diagnosis and mefloquine-artesunate treatment of falciparum malaria in Thailand: the Tak Malaria Initiative.
    Carrara VI; Sirilak S; Thonglairuam J; Rojanawatsirivet C; Proux S; Gilbos V; Brockman A; Ashley EA; McGready R; Krudsood S; Leemingsawat S; Looareesuwan S; Singhasivanon P; White N; Nosten F
    PLoS Med; 2006 Jun; 3(6):e183. PubMed ID: 16719547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The co-existence of Plasmodium: sidelights from falciparum and vivax malaria in Thailand.
    Snounou G; White NJ
    Trends Parasitol; 2004 Jul; 20(7):333-9. PubMed ID: 15193565
    [No Abstract]   [Full Text] [Related]  

  • 16. Chloroquine resistant malaria in neonates.
    Khichi QK; Channar MS; Wairraich MI; Butt A
    J Coll Physicians Surg Pak; 2005 Jan; 15(1):34-6. PubMed ID: 15670522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How benign is benign tertian malaria?
    Sharma A; Khanduri U
    J Vector Borne Dis; 2009 Jun; 46(2):141-4. PubMed ID: 19502694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resurgence of malaria and drug resistance in plasmodium falciparum and plasmodium vivax species in Bombay.
    Potkar CN; Kshirsagar NA; Kathuria R
    J Assoc Physicians India; 1995 May; 43(5):336-8. PubMed ID: 9081964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The phenomenon of the delayed initial attack of tertian malaria].
    Silbermann MH; Stuiver PC
    Ned Tijdschr Geneeskd; 1992 Oct; 136(40):1984-7. PubMed ID: 1407184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The diagnosis and treatment of malaria in Australia.
    Currie B
    Aust Fam Physician; 1993 Oct; 22(10):1773-6, 1779. PubMed ID: 8280001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.